Search Results - "Kim, Ye Seon"

Refine Results
  1. 1

    Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer by Jung, Sangyong, Kim, Dong Ha, Choi, Yun Jung, Kim, Seon Ye, Park, Hyojeong, Lee, Hyeonjeong, Choi, Chang-Min, Sung, Young Hoon, Lee, Jae Cheol, Rho, Jin Kyung

    Published in Scientific reports (04-10-2021)
    “…The emergence of resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) with activating…”
    Get full text
    Journal Article
  2. 2

    Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer by Kim, Dong Ha, Kim, HyeongRyul, Choi, Yun Jung, Kim, Seon Ye, Lee, Jung-Eun, Sung, Ki Jung, Sung, Young Hoon, Pack, Chan-Gi, Jung, Min-kyo, Han, Buhm, Kim, Kunhee, Kim, Woo Sung, Nam, Soo Jeong, Choi, Chang-Min, Yun, Miyong, Lee, Jae Cheol, Rho, Jin Kyung

    Published in Experimental & molecular medicine (09-08-2019)
    “…Programmed cell death protein-1/programmed cell death ligand-1 (PD-1/PD-L1) pathway blockade is a promising new cancer therapy. Although PD-1/PD-L1 treatment…”
    Get full text
    Journal Article
  3. 3

    MET and AXL Inhibitor NPS-1034 Exerts Efficacy against Lung Cancer Cells Resistant to EGFR Kinase Inhibitors Because of MET or AXL Activation by JIN KYUNG RHO, YUN JUNG CHOI, JAE CHEOL LEE, SEON YE KIM, TAE WON KIM, EUN KYUNG CHOI, YOON, Seon-Joo, BU MAN PARK, EUNHYE PARK, JONG HWAN BAE, CHOI, Chang-Min

    Published in Cancer research (Chicago, Ill.) (2014)
    “…In non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations, acquired resistance to EGFR-tyrosine kinase inhibitors (EGFR-TKI)…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer by Cho, Yong-Hee, Choi, Myeong Geun, Kim, Dong Ha, Choi, Yun Jung, Kim, Seon Ye, Sung, Ki Jung, Lee, Jae Cheol, Kim, Sang-Yeob, Rho, Jin Kyung, Choi, Chang-Min

    Published in Targeted oncology (01-04-2020)
    “…Background Immunotherapy with immune checkpoint inhibitors for non-small cell lung cancer (NSCLC) has emerged as an important treatment option. Although…”
    Get full text
    Journal Article
  6. 6
  7. 7

    AUY922 effectively overcomes MET- and AXL-mediated resistance to EGFR-TKI in lung cancer cells by Choi, Yun Jung, Kim, Seon Ye, So, Kwang Sup, Baek, In-Jeoung, Kim, Woo Sung, Choi, Se Hoon, Lee, Jae Cheol, Bivona, Trever G, Rho, Jin Kyung, Choi, Chang-Min

    Published in PloS one (17-03-2015)
    “…The activation of bypass signals, such as MET and AXL, has been identified as a possible mechanism of EGFR-TKI resistance. Because various oncoproteins depend…”
    Get full text
    Journal Article
  8. 8

    Ethyl pyruvate stabilizes hypoxia-inducible factor 1 alpha via stimulation of the TCA cycle by Kim, Seon-Ye, Choi, Jae-Sun, Park, Chan, Jeong, Joo-Won

    Published in Cancer letters (28-09-2010)
    “…Abstract Ethyl pyruvate is a simple derivative of the endogenous metabolite pyruvate. Pyruvate is the starting substrate for the tricarboxylic acid (TCA) cycle…”
    Get full text
    Journal Article
  9. 9

    Okadaic acid protects human neuroblastoma SH-SY5Y cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis by Ahn, Kook-Hee, Kim, Young-Sun, Kim, Seon-Ye, Huh, Youngbuhm, Park, Chan, Jeong, Joo-Won

    Published in Neuroscience letters (09-01-2009)
    “…1-Methyl-4-phenylpyridinium ion (MPP +) has been shown to selectively inhibit mitochondrial function and induce a parkinsonism-like syndrome. MPP + stimulates…”
    Get full text
    Journal Article
  10. 10

    Discovery of a Potent and Mutant-Selective EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Lung Cancer by Kim, Dong Ha, Choi, Yun Jung, Kim, Seon Ye, Lee, Jung-Eun, Sung, Ki Jung, Sung, Young Hoon, Kim, Woo Sung, Kim, Sung-Eun, Ryu, Hyung Chul, Kim, Jae Sun, Guangying, Lu, Choi, Chang-Min, Rho, Jin Kyung, Lee, Jae Cheol

    Published in Targeted oncology (01-06-2018)
    “…Background Despite remarkable activity in epidermal growth factor receptor (EGFR)-mutant lung cancer patients, the clinical efficacy of EGFR tyrosine kinase…”
    Get full text
    Journal Article
  11. 11

    Okadaic acid promotes angiogenesis via activation of hypoxia-inducible factor-1 by Kim, Young-Sun, Ahn, Kook-Hee, Kim, Seon-Ye, Jeong, Joo-Won

    Published in Cancer letters (08-04-2009)
    “…Abstract Okadaic acid, a potent tumor promoter and an inhibitor of protein phosphatase 1 and 2A, has also been characterized as an angiogenic inducer in the…”
    Get full text
    Journal Article
  12. 12

    Neuroendocrine differentiation in acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitor by Chang, Youjin, Kim, Seon Ye, Choi, Yun Jung, So, Kwang Sup, Rho, Jin Kyung, Kim, Woo Sung, Lee, Jae Cheol, Chung, Jin-Haeng, Choi, Chang-Min

    Published in Tuberculosis and respiratory diseases (01-09-2013)
    “…Small cell lung cancer (SCLC) transformation during epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in lung cancer has been…”
    Get full text
    Journal Article
  13. 13

    Isovaleric acid ameliorates ovariectomy‐induced osteoporosis by inhibiting osteoclast differentiation by Cho, Kwang Min, Kim, Ye Seon, Lee, Mingyu, Lee, Ha Young, Bae, Yoe‐Sik

    Published in Journal of cellular and molecular medicine (01-05-2021)
    “…Osteoclasts (OCs) play important roles in bone remodelling and contribute to bone loss by increasing bone resorption activity. Excessively activated OCs cause…”
    Get full text
    Journal Article
  14. 14

    WKYMVm ameliorates obesity by improving lipid metabolism and leptin signalling by Kang, Ji Hyeon, Kim, Hyung Sik, Park, Seon Hyang, Kim, Ye Seon, Bae, Yoe‐Sik

    Published in Journal of cellular and molecular medicine (01-09-2023)
    “…Abstract Obesity is a metabolic disorder that results from an imbalance of energy intake and consumption. As low‐grade chronic inflammation caused by obesity…”
    Get full text
    Journal Article
  15. 15

    Therapeutic effects of a phospholipase D1 inhibitor against polymicrobial sepsis by Bae, Yoe-Sik, Lee, Sung Kyun, Kim, Ye Seon, Lee, Ha Young

    Published in The Journal of immunology (1950) (01-05-2019)
    “…Abstract In this study, we found that a phospholipase D1-selective inhibitor (VU0155069), significantly increased survival rate against cecal ligation and…”
    Get full text
    Journal Article
  16. 16

    CD200Rhigh neutrophils with dysfunctional autophagy establish systemic immunosuppression by increasing regulatory T cells by Kim, Ye Seon, Jeong, Yu Sun, Bae, Geon Ho, Kang, Ji Hyeon, Lee, Mingyu, Zabel, Brian A., Bae, Yoe-Sik

    Published in Cellular & molecular immunology (01-04-2024)
    “…Distinct neutrophil populations arise during certain pathological conditions. The generation of dysfunctional neutrophils during sepsis and their contribution…”
    Get full text
    Journal Article
  17. 17

    Unique characteristics of lung-resident neutrophils are maintained by PGE2/PKA/Tgm2-mediated signaling by Bae, Geon Ho, Kim, Ye Seon, Park, Ji Ye, Lee, Mingyu, Lee, Sung Kyun, Kim, Ji Cheol, Kim, Jang Gyu, Shin, Ye Ji, Lee, Ho, Kim, Soo-Youl, Bae, Yong-Soo, Zabel, Brian A., Kim, Hong Sook, Bae, Yoe-Sik

    Published in Blood (25-08-2022)
    “…Lung-resident neutrophils need to be tightly regulated to avoid degranulation- and cytokine-associated damage to fragile alveolar structures that can lead to…”
    Get full text
    Journal Article
  18. 18

    IM156, a new AMPK activator, protects against polymicrobial sepsis by Kang, Ji Hyeon, Lee, Sung Kyun, Yun, Nam Joo, Kim, Ye Seon, Song, Jason Jungsik, Bae, Yoe‐Sik

    Published in Journal of cellular and molecular medicine (01-06-2022)
    “…IM156, a novel biguanide with higher potency of AMP‐activated protein kinase activation than metformin, has inhibitory activity against angiogenesis and…”
    Get full text
    Journal Article
  19. 19

    AKT/mTOR down-regulation by CX-4945, a CK2 inhibitor, promotes apoptosis in chemorefractory non-small cell lung cancer cells by So, Kwang Sup, Rho, Jin Kyung, Choi, Yun Jung, Kim, Seon Ye, Choi, Chang Min, Chun, Young Jin, Lee, Jae Cheol

    Published in Anticancer research (01-03-2015)
    “…The response to chemotherapeutic drugs in non-small cell lung cancer (NSCLC) is unsatisfactory, leading to poor outcomes. This study the aimed to investigates…”
    Get full text
    Journal Article
  20. 20

    VU0155069 inhibits inflammasome activation independent of phospholipase D1 activity by Lee, Sung Kyun, Kim, Ye Seon, Bae, Geon Ho, Lee, Ha Young, Bae, Yoe-Sik

    Published in Scientific reports (04-10-2019)
    “…The inflammasome is a specialized multiprotein oligomer that regulates IL-1β production. Although regulation of the inflammasome is related to crucial…”
    Get full text
    Journal Article